Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Miles, Dale"'
Autor:
Deng R; Genentech Inc., South San Francisco, CA, USA. deng.rong@gene.com.; Clinical Pharmacology, Genentech Research and Early Development, 1 DNA Way, MS463a, South San Francisco, CA, 94080, USA. deng.rong@gene.com., Gibiansky L; QuantPharm, LLC, North Potomac, MD, USA., Lu T; Genentech Inc., South San Francisco, CA, USA., Agarwal P; Genentech Inc., South San Francisco, CA, USA., Ding H; Genentech Inc., South San Francisco, CA, USA., Li X; Genentech Inc., South San Francisco, CA, USA., Kshirsagar S; Genentech Inc., South San Francisco, CA, USA., Lu D; Genentech Inc., South San Francisco, CA, USA., Li C; Genentech Inc., South San Francisco, CA, USA., Girish S; Genentech Inc., South San Francisco, CA, USA., Wang J; Genentech Inc., South San Francisco, CA, USA., Boyer M; Roche Products Limited, Welwyn Garden City, UK., Humphrey K; Roche Products Limited, Welwyn Garden City, UK., Freise KJ; AbbVie, North Chicago, IL, USA., Salem AH; AbbVie, North Chicago, IL, USA., Seymour JF; Royal Melbourne Hospital, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, VIC, Australia., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam on behalf of HOVON CLL WG, Amsterdam, The Netherlands., Miles D; Genentech Inc., South San Francisco, CA, USA.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2019 Dec; Vol. 58 (12), pp. 1621-1634.